Eliciting the mitochondrial unfolded protein response via NAD+ repletion reverses fatty liver disease

Conclusion: Our data warrant the future evaluation of NAD+ boosting strategies to manage the development or progression of NAFLD. This article is protected by copyright. All rights reserved.

Source: Hepatology - September 24, 2015 Category: Internal Medicine Authors: Karim Gariani, Keir J. Menzies, Dongryeol Ryu, Casey J. Wegner, Xu Wang, Eduardo R. Ropelle, Norman Moullan, Hongbo Zhang, Alessia Perino, Vera Lemos, Bohkyung Kim, Young‐Ki Park, Alessandra Piersigilli, Tho X. Pham, Yue Yang, Chai Siah Ku, Sung I. Koo, Tags: Steatohepatitis and Metabolic Liver Disease Source Type: research